{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:16:14Z","timestamp":1740125774403,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IIR 16-210"],"award-info":[{"award-number":["IIR 16-210"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s11606-021-06780-y","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T15:03:27Z","timestamp":1622214207000},"page":"3689-3696","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Benzodiazepine Prescribing from VA and Medicare to Dually Enrolled Older Veterans: A Retrospective Cohort Study"],"prefix":"10.1007","volume":"36","author":[{"given":"Lianlian","family":"Lei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Strominger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilse R.","family":"Wiechers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Myra","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic C.","family":"Blow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy S. B.","family":"Bohnert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lillian","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah L.","family":"Krein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4740-2640","authenticated-orcid":false,"given":"Donovan T.","family":"Maust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,28]]},"reference":[{"issue":"5","key":"6780_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s002280100326","volume":"57","author":"A Fourrier","year":"2001","unstructured":"Fourrier A, Letenneur L, Dartigues JF, Moore N, B\u00e9gaud B. Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use. Eur J Clin Pharmacol 2001;57(5):419-425.","journal-title":"Eur J Clin Pharmacol"},{"issue":"26","key":"6780_CR2","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1056\/NEJM198812293192604","volume":"319","author":"ME Tinetti","year":"1988","unstructured":"Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988;319(26):1701-1707.","journal-title":"N Engl J Med"},{"issue":"14","key":"6780_CR3","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1001\/archinte.164.14.1567","volume":"164","author":"AK Wagner","year":"2004","unstructured":"Wagner AK, Zhang F, Soumerai SB, et al. Benzodiazepine Use and Hip Fractures in the Elderly: Who Is at Greatest Risk? Arch Intern Med 2004;164(14):1567-1572.","journal-title":"Arch Intern Med"},{"issue":"8","key":"6780_CR4","first-page":"639","volume":"29","author":"C Tannenbaum","year":"2012","unstructured":"Tannenbaum C, Paquette A, Hilmer S, Holroyd-Leduc J, Carnahan R. A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging 2012;29(8):639-658.","journal-title":"Drugs Aging"},{"issue":"7","key":"6780_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1001\/jama.2013.272","volume":"309","author":"CM Jones","year":"2013","unstructured":"Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013;309(7):657-659.","journal-title":"JAMA."},{"key":"6780_CR6","unstructured":"Wisely AC. American Geriatrics Society: Ten Things Physicians and Patients Should Question. http:\/\/www.choosingwisely.org\/societies\/american-geriatrics-society\/. Accessed August 2, 2017."},{"issue":"4","key":"6780_CR7","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2019","unstructured":"American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2019 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2019;67(4):674-694.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"6780_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/jgs.16825","volume":"69","author":"DT Maust","year":"2021","unstructured":"Maust DT, Kim HM, Wiechers IR, Ignacio RV, Bohnert ASB, Blow FC. Benzodiazepine Use among Medicare, Commercially Insured, and Veteran Older Adults, 2013-2017. J Am Geriatr Soc 2021;69(1):98-105.","journal-title":"J Am Geriatr Soc"},{"key":"6780_CR9","unstructured":"Huang G, Kim S, Muz B, Gasper J. 2017 Survey of Veteran Enrollees\u2019 Health and Use of Health Care. 2018. http:\/\/www.va.gov\/HEALTHPOLICYPLANNING\/SoE2017\/VA_Enrollees_Report_Data_Findings_Report2.pdf Accessed on September 22, 2020."},{"issue":"11","key":"6780_CR10","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1001\/jamainternmed.2019.2788","volume":"179","author":"JM Thorpe","year":"2019","unstructured":"Thorpe JM, Thorpe CT, Schleiden L, et al. Association between dual use of Department of Veterans Affairs and Medicare Part D drug benefits and potentially unsafe prescribing. JAMA Intern Med 2019;179(11):1584-1586.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"6780_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.7326\/M16-0551","volume":"166","author":"JM Thorpe","year":"2017","unstructured":"Thorpe JM, Thorpe CT, Gellad WF, et al. Dual health care system use and high-risk prescribing in patients with dementia: a national cohort study. Ann Intern Med 2017;166(3):157-163.","journal-title":"Ann Intern Med"},{"issue":"2","key":"6780_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2105\/AJPH.2017.304174","volume":"108","author":"WF Gellad","year":"2018","unstructured":"Gellad WF, Thorpe JM, Zhao X, et al. Impact of dual use of Department of Veterans Affairs and Medicare Part D drug benefits on potentially unsafe opioid use. Am J Public Health 2018;108(2):248.","journal-title":"Am J Public Health"},{"issue":"7","key":"6780_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.7326\/M18-2574","volume":"170","author":"P Moyo","year":"2019","unstructured":"Moyo P, Zhao X, Thorpe CT, et al. Dual Receipt of Prescription Opioids From the Department of Veterans Affairs and Medicare Part D and Prescription Opioid Overdose Death Among Veterans: A Nested Case\u2013Control Study. Ann Intern Med 2019;170(7):433-442.","journal-title":"Ann Intern Med"},{"key":"6780_CR14","unstructured":"Centers for Medicare & Medicaid Services. Transition to Part D Coverage of Benzodiazepines and Barbiturates Beginning in 2013. https:\/\/www.cms.gov\/Medicare\/Prescription-Drug-Coverage\/PrescriptionDrugCovContra\/Downloads\/BenzoandBarbituratesin2013.pdf Accessed May 6, 2016."},{"key":"6780_CR15","unstructured":"The Henry J. Kaiser Family Foundation. An Overview of the Medicare Part D Prescription Drug Benefit. https:\/\/www.kff.org\/medicare\/fact-sheet\/an-overview-of-the-medicare-part-d-prescription-drug-benefit\/. Accessed February 3, 2021."},{"key":"6780_CR16","unstructured":"The Henry J. Kaiser Family Foundation. An Overview of Medicare. https:\/\/www.kff.org\/medicare\/issue-brief\/an-overview-of-medicare\/ Accessed February 3, 2021."},{"issue":"4","key":"6780_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1191\/0269216306pm1151oa","volume":"20","author":"M Henderson","year":"2006","unstructured":"Henderson M, MacGregor E, Sykes N, Hotopf M. The use of benzodiazepines in palliative care. Palliat Med 2006;20(4):407-412.","journal-title":"Palliat Med"},{"issue":"4","key":"6780_CR18","doi-asserted-by":"publisher","first-page":"e202051","DOI":"10.1001\/jamanetworkopen.2020.2051","volume":"3","author":"DT Maust","year":"2020","unstructured":"Maust DT, Lin LA, Goldstick JE, Haffajee RL, Brownlee R, Bohnert AS. Association of Medicare Part D benzodiazepine coverage expansion with changes in fall-related injuries and overdoses among Medicare advantage beneficiaries. JAMA Netw Open 2020;3(4):e202051-e202051.","journal-title":"JAMA Netw Open"},{"key":"6780_CR19","unstructured":"Derrick B, Dobson-Mckittrick A, Toher D, White P. Test statistics for comparing two proportions with partially overlapping samples. J Appl Quant Methods. 2015;10(3)."},{"key":"6780_CR20","unstructured":"U.S. Department of Veterans Affairs. Enrollment Priority Groups. https:\/\/www.va.gov\/healthbenefits\/resources\/publications\/IB10-441_enrollment_priority_groups.pdf. Published 2018. Accessed January 27, 2020."},{"key":"6780_CR21","doi-asserted-by":"crossref","unstructured":"van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care 2009:626-633.","DOI":"10.1097\/MLR.0b013e31819432e5"},{"issue":"7","key":"6780_CR22","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1001\/jamapsychiatry.2013.908","volume":"70","author":"MA Ilgen","year":"2013","unstructured":"Ilgen MA, Kleinberg F, Ignacio RV, et al. Noncancer pain conditions and risk of suicide. JAMA Psychiatry 2013;70(7):692-697.","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"6780_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1207\/S15328031US0104_02","volume":"1","author":"H Goldstein","year":"2002","unstructured":"Goldstein H, Browne W, Rasbash J. Partitioning variation in multilevel models. Underst Stats 2002;1(4):223-231.","journal-title":"Underst Stats"},{"key":"6780_CR24","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2019. http:\/\/www.R-project.org\/"},{"issue":"1","key":"6780_CR25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.32614\/RJ-2018-017","volume":"10","author":"P B\u00fcrkner","year":"2018","unstructured":"B\u00fcrkner P. Advanced Bayesian Multilevel Modeling with the R Package brms. The R Journal 2018;10(1): 395-411.","journal-title":"The R Journal"},{"issue":"5","key":"6780_CR26","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/j.pain.0000000000000837","volume":"158","author":"LA Lin","year":"2017","unstructured":"Lin LA, Bohnert AS, Kerns RD, Clay MA, Ganoczy D, Ilgen MA. Impact of the opioid safety initiative on opioid-related prescribing in veterans. Pain. 2017;158(5):833-839.","journal-title":"Pain."},{"issue":"5","key":"6780_CR27","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s11606-019-05404-w","volume":"35","author":"JT Kullgren","year":"2020","unstructured":"Kullgren JT, Fagerlin A, Kerr EA. Completing the MISSION: a blueprint for helping veterans make the most of new choices. J Gen Intern Med 2020;35(5):1567-1570.","journal-title":"J Gen Intern Med"},{"issue":"9","key":"6780_CR28","doi-asserted-by":"publisher","first-page":"593","DOI":"10.7326\/M18-0852","volume":"169","author":"R Carico","year":"2018","unstructured":"Carico R, Zhao X, Thorpe CT, et al. Receipt of overlapping opioid and benzodiazepine prescriptions among veterans dually enrolled in Medicare Part D and the Department of Veterans Affairs: a cross-sectional study. Ann Intern Med 2018;169(9):593-601.","journal-title":"Ann Intern Med"},{"issue":"5","key":"6780_CR29","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s11606-016-3631-4","volume":"31","author":"TR Radomski","year":"2016","unstructured":"Radomski TR, Zhao X, Thorpe CT, et al. VA and medicare utilization among dually enrolled veterans with type 2 diabetes: a latent class analysis. J Gen Intern Med 2016;31(5):524-531.","journal-title":"J Gen Intern Med"},{"issue":"Suppl 3","key":"6780_CR30","doi-asserted-by":"publisher","first-page":"5140","DOI":"10.1111\/1475-6773.13029","volume":"53","author":"CF Liu","year":"2018","unstructured":"Liu CF, Batten A, Wong ES, Fihn SD, Hebert PL. Fee-for-Service Medicare-Enrolled Elderly Veterans Are Increasingly Voting with Their Feet to Use More VA and Less Medicare, 2003-2014. Health Serv Res 2018;53 Suppl 3:5140-5158.","journal-title":"Health Serv Res"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-021-06780-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-021-06780-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-021-06780-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T01:09:11Z","timestamp":1653700151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-021-06780-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,28]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6780"],"URL":"https:\/\/doi.org\/10.1007\/s11606-021-06780-y","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"type":"print","value":"0884-8734"},{"type":"electronic","value":"1525-1497"}],"subject":[],"published":{"date-parts":[[2021,5,28]]},"assertion":[{"value":"23 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no further conflicts to disclose. Dr. Wiechers is National Program Director of the VA Psychotropic Drug Safety Initiative.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}